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Abstract
Interleukin (IL)-38 is a member of the IL-1 family of cytokines, which was proposed to exert
anti-inflammatory effects. IL-38 is constitutively expressed in the skin, where keratinocytes
are the main producing cells. Little information is currently available concerning IL-38 biol-
ogy. Here, we investigated the subcellular localization and interaction partners of the IL-38
protein in human keratinocytes. IL-38 expression was reduced in primary keratinocytes
grown in monolayer (2D) cultures. We thus used IL-38 overexpressing immortalized normal
human keratinocytes (NHK/38) to study this cytokine in cell monolayers. In parallel, differen-
tiation of primary human keratinocytes in an in vitro reconstructed human epidermis (RHE)
3D model allowed us to restore endogenous IL-38 expression. In NHK/38 cells and in RHE,
IL-38 was mainly cell-associated, rather than released into culture supernatants. Intracellu-
lar IL-38 was preferentially, although not exclusively, cytoplasmic. Similarly, in normal
human skin sections, IL-38 was predominantly cytoplasmic in the epidermis and essentially
excluded from keratinocyte nuclei. A yeast two-hybrid screen identified destrin/actin-depoly-
merizing factor (DSTN) as a potential IL-38-interacting molecule. Co-immunoprecipitation
and proximity ligation assay confirmed this interaction. We further observed partial co-locali-
zation of IL-38 and DSTN in NHK/38 cells. Endogenous IL-38 and DSTN were also co-
expressed in all epidermal layers in RHE and in normal human skin. Finally, IL-38 partially
co-localized with F-actin in NHK/38 cells, in particular along the cortical actin network and in
filopodia. In conclusion, IL-38 is found predominantly in the cytoplasm of human keratino-
cytes, where it interacts with DSTN. The functional relevance of this interaction remains to
be investigated.
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Introduction
The interleukin (IL)-1 family of cytokines includes seven pro-inflammatory agonists (IL-1α
IL-1β, IL-18, IL-33, IL-36α, IL-36β and IL-36γ) and four members with antagonist or anti-
inflammatory activity (IL-1Ra, IL-36Ra, IL-37 and IL-38) [1]. The agonistic cytokines play
essential roles in host defense, but they also cause immunopathology and their activity is con-
trolled at many levels, including regulation of their production, maturation and release, as well
as inhibition of their biological effects by decoy receptors and antagonists, which limit inflam-
matory responses [2, 3].
IL-38 (IL-1F10, IL-1HY2) was initially proposed to act as an IL-1 family receptor antagonist
based on its sequence similarity with IL-1Ra and IL-36Ra [4]. Subsequently, anti-inflammatory
effects of IL-38 were observed in cultured cells [5–9] and overexpression of IL-38 or adminis-
tration of the recombinant protein attenuated disease symptoms in several mouse models of
inflammation [7, 9–13]. In humans, elevated IL-38 expression or serum levels have been
reported in a number of inflammatory and autoimmune diseases, with the notable exception
of inflammatory skin disorders, in which IL-38 expression appears to be rather reduced [6, 9,
14–21]. In any case, a potential role of IL-38 in these conditions remains to be established.
Likewise, IL1F10 gene polymorphisms have been associated with inflammatory diseases or dis-
ease markers [22–29], but it is currently unclear whether these associations represent causal
relationships.
IL-38 is constitutively expressed in the skin, where keratinocytes are the main producing
cells [30]. Little information is currently available concerning subcellular localization, post-
translational maturation, release or secretion of the IL-38 protein, or even potential intracellu-
lar functions of this cytokine, as suggested for other IL-1 family members [31]. In this study,
we examined the localization of the IL-38 protein in human keratinocytes, which was predom-
inantly cytoplasmic in monolayer and 3D cultures, as well as in normal human epidermis. We
further identified destrin/actin-depolymerizing factor (DSTN) as an IL-38 interacting protein
and observed partial co-localization of IL-38 with DSTN, as well as with F-actin, in particular
along the cell cortex and in filopodia.
Materials and methods
Cloning of human IL-38 expression vectors
The human full-length IL-38 coding sequence (GenBank accession n˚ NM_173161.3, bp 76–
534) was amplified by RT-PCR on total RNA extracted from cultured human primary kerati-
nocytes using the following primers: forward 5’-AAGCTTGACACCACTGATTGCAGG
AATG-3’; reverse 5’-CTCGAGGTTTCCTGTCTCCCTACCAGCTCTG-3’. The cDNA
was then cloned into the pcDNA3.1(+) vector (Thermo Fisher Scientific AG) to obtain plas-
mid pcDNA3.1/hIL-38 for IL-38 overexpression under the control of the CMV promoter in
human embryonic kidney (HEK) 293T cells or into pcDNA4/TO (Thermo Fisher Scientific
AG) to obtain the plasmid pcDNA4/TO/hIL-38 for inducible IL-38 expression in an immortal-
ized normal human keratinocyte (NHK) cell line [32]. For both constructs, the sequence of the
entire coding region and of the vector-insert junctions was verified before use.
Human skin samples
Skin biopsies were taken from healthy adults undergoing surgery at the Department of Plastic
and Reconstructive Surgery of the Geneva University Hospitals in Switzerland, or children
undergoing surgery at the Polish-American Children’s Hospital in Cracow, Poland. This study
was conducted according to the Declaration of Helsinki, and approved by the local ethics
IL-38 localisation and interaction partners in keratinocytes
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committees of the University Hospitals of Geneva (protocol 06–063), or of the Jagiellonian
University in Cracow according to Polish law (No. 1072.6120.9.2017), as appropriate. Written
informed consent was obtained for each individual. For histology, skin biopsies were fixed in
4% buffered formaldehyde and embedded in paraffin. For RNA extraction, the skin was rinsed
in PBS containing 100 U/ml penicillin and 100 μg/ml streptomycin (P/S) and incubated in
Dispase (5U/ml, STEMCELL Technologies, Vancouver, Canada) overnight at 4˚C to detach
the epidermis from the dermis. Both layers were then collected and frozen separately. For the
isolation of primary human keratinocytes, the skin was rinsed in PBS, P/S and incubated in
Dispase overnight at 4˚C. The epidermis was then detached from the dermis and treated 3
times for 1 minute with 0.05% Trypsin, 0.02% EDTA. Isolated cells were cultured in Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma-Aldrich Chemie GmbH) supplemented with
10% fetal bovine serum (Sigma-Aldrich Chemie GmbH) and P/S. After 24 h, the medium was
changed to fully supplemented serum-free Keratinocyte Growth Medium 2 (KBM-2; Promo-
cell, Heidelberg, Germany).
Cell culture and transfection
NHK cells were cultured in keratinocyte-serum free medium (K-SFM, Thermo Fisher Scien-
tific AG), supplemented with bovine pituitary extract and human recombinant epidermal
growth factor (Thermo Fisher Scientific AG), penicillin and streptomycin, at 37˚C in a humid-
ified atmosphere containing 5% CO2. For doxycycline (Dox)-inducible IL-38 overexpression,
we used the T-REx system (Thermo Fisher Scientific AG). NHK cells were first transfected
with the pcDNA6/TR vector, which encodes the tetracycline repressor (TR) protein, using the
Neon transfection system (Thermo Fisher Scientific AG) according to the manufacturer’s
instructions. Briefly, 106 NHK cells were trypsinized, resuspended in 100 μl buffer R, added to
2 μg/ml of plasmid DNA and electroporated using the following parameters: pulse voltage
1100, pulse width 20, pulse number 2. Stably transfected cells were then selected with 1 μg/ml
blasticidin and limiting dilution cloning was used to isolate a clone expressing high levels of
TR. This clone was further transfected with pcDNA4/TO/hIL-38. Stable transfectants were
selected with 100 μg/ml zeocin to obtain a population of NHK/38 cells containing both plas-
mids, which were maintained in 0.5 μg/ml blasticidin and 300 μg/ml zeocin. Alternatively,
transfection with pcDNA4/TO/LacZ, followed by similar selection, yielded NHK/lacZ cells
inducibly overexpressing E. Coli β-galactosidase, which were used as negative controls for
immunofluorescence experiments. To induce IL-38 expression, NHK/38 cells were treated
with Dox at 1 μg/ml for 24h. To promote differentiation of NHK/38 cells in monolayer (2D)
cultures, medium was switched to DMEM (4.5 g/l glucose) containing 1.8 mM Ca++, supple-
mented with L-glutamine, streptomycin, penicillin and 10% FCS [32]. Primary human kerati-
nocytes were grown in KBM-2 medium containing 0.06 mM Ca++. To induce differentiation
in monolayer (2D) cultures, medium was additionally supplemented with 2 mM Ca++. For 3D
differentiation of in vitro reconstructed human epidermis (RHE), 5x105 primary juvenile kera-
tinocytes were plated onto ThinCert cell culture inserts (Greiner Bio-One Vacuette Schweiz
GmbH, St Gallen, Switzerland) and grown to confluency in CnT-Prime medium (CELLnTEC
Advanced Cell Systems AG, Bern, Switzerland). The medium was then switched to CnT-Prime
3D Barrier medium and the cells cultured at the air-liquid interface. Human embryonic kidney
(HEK) 293T cells were cultured in DMEM (4.5 g/l glucose) supplemented with L-glutamine,
streptomycin, penicillin and 10% FCS. For transfection, HEK 293T cells were plated at a den-
sity of 2x105 cells/ml and transfected 24 hours after seeding by calcium phosphate precipitation
(Promega AG) with 0.5–1 μg/ml of pcDNA3.1/hIL-38 and/or pcDNA3.1/hDSTN (clone
IL-38 localisation and interaction partners in keratinocytes
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OHu30126C, Genescript Piscataway, NJ; GenBank accession n˚ NM_006870.3), or with empty
pcDNA3.1(+) as a negative control.
RNA extraction and RTqPCR
Total RNA was extracted from human epidermis and dermis using the mirVana RNA isolation
kit (Thermo Fisher Scientific AG), from monolayer cultures of NHK and primary cells using
the TRIzol1 reagent (Life Technologies), and from RHE using the RNeasy Micro (Qiagen
AG, Hombrechtikon, Switzerland) or the Quick-RNA Microprep (Zymo Research Corpora-
tion, Irvine, CA) kits. Total RNA was treated with RNAse free DNAse (Promega AG) and
250–500 ng were reverse transcribed using the SuperScript II Reverse transcriptase (Thermo
Fisher Scientific AG). Gene expression levels were determined by quantitative PCR with a
SYBR Green PCR master mix (Bio-Rad Laboratories AG, Cressier, Switzerland) and normal-
ized to glucuronidase-β (GUSB) mRNA levels using a comparative method (2-ΔCt). Non-
reverse-transcribed RNA samples and buffer were included as negative controls. The primer
sequences (Eurofins, Ebersberg, Germany) used to detect IL-38 (IL1F10), keratin 10 (KRT10),
involucrin (IVL), filaggrin (FLG) and GUSB are shown in Table 1.
ELISA
NHK/38 cells were seeded in 96-well plates a density of 7.5x104 cells/well and incubated on the
following day with or without 1 μg/ml Dox for 24h. Culture supernatants were collected and
cells were lyzed in culture medium containing 0.1% Triton X-100. To assess IL-38 release by
RHE, culture media were collected 24h after the last medium change and concentrated 25 fold
using a Centricon Plus-20 column (Merck & Cie, Schaffhausen, Switzerland) with a molecular
weight cut-off of 5 kDa for cytokine detection by ELISA. RHE were lyzed by repeated freeze-
thawing in 100 μl TNN buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40)
supplemented with a protease inhibitor cocktail (Sigma-Aldrich Chemie GmbH). Samples
were cleared by centrifugation and total protein content was assessed with the DC protein
assay kit (Bio-Rad Laboratories AG). IL-38 levels were determined using a human IL-38 Duo-
Set ELISA Development System (DY9110-05, R&D Systems).
Histology and immunohistochemistry
RHEs were fixed in 4% formaldehyde and embedded in paraffin. For evaluation of the mor-
phology, 5 μm sections were stained with hematoxylin (Merck & Cie) and eosin (Sigma-
Aldrich Chemie GmbH). For immunohistochemistry, antigen retrieval was performed in 10
mM citrate buffer pH 6.0 for 30 min at 95˚C. Sections were stained using the R.T.U. Vectastain
Table 1. Primers used for qPCR.
Gene Accession number Primer sequence Amplicon (bp)
IL1F10 NM_173161.3 Fwd 5’-CCCCATGGCAAGATACTAC-3’
Rev 5’-CCTCTTCTGTCTCCACACAT-3’
215
KRT10 NM_000421.4 Fwd 5'-TCCCAACTGGCCTTGAAACA-3'
Rev 5'-TGAGAGCTGCACACAGTAGC-3’
75
IVL NM_005547.3 Fwd 5'-TTGCTTCCTGTAGAGCACCA-3'
Rev 5'-TAGCGGACCCGAAATAAGTG-3’
146
FLG NM_002016.1 Fwd 5'-AAGGTTCACATTTATTGCCAAA-3'
Rev 5'-GGATTTGCCGAAATTCCTTT-3’
157
GUSB NM_000181.4 Fwd 5’-CCACCAGGGACCATCCAAT-3’
Rev 5’-AGTCAAAATATGTGTTCTGGACAAAGTAA-3’
79
https://doi.org/10.1371/journal.pone.0225782.t001
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Kit with ImmPACT AMEC Red Substrate (Vector Laboratories, Burlingame, CA, USA)
according to the manufacturer’s protocol. The following antibodies were used: rabbit mono-
clonal anti-Ki67 (clone SP6, Thermo Fisher Scientific AG, 1/200), rabbit polyclonal anti-invo-
lucrin (Abcam, Cambridge, U.K., 1/1000), mouse monoclonal anti-filaggrin (clone FLG/1561,
Abcam, 1/600) and rabbit monoclonal anti-keratin 10 (clone EP1607IHCY, Abcam, 1/5000).
Sections were counterstained with haematoxylin solution, mounted with Glycerol Mounting
Medium (Dako) and then images were taken using Zeiss Axioscan.Z1 (Carl Zeiss Microscopy)
and analyzed with ZEN black software (Carl Zeiss Microscopy).
Immunofluorescence
NHK/38 and NHK/lacZ cells were seeded in chamber slides at a density of 1.6x105 cells/well
and incubated on the following day with or without 1 μg/ml Dox for 24h. HEK 293T cells were
seeded in chamber slides, transiently transfected with pcDNA3.1/hIL-38, pcDNA3.1/hDSTN,
or empty pcDNA3.1(+) as a control, and used 24 to 48h after transfection. Cells were fixed
(PBS, 2% paraformaldehyde), permeabilized (PBS, 0.1% Triton X-100) and washed (Dako
wash buffer, Agilent Technologies AG), before staining with a polyclonal goat anti-IL38 anti-
body (AF2427, R&D Systems, Abingdon, UK, 1/1000), a monoclonal mouse anti-hIL-38 anti-
body (H127C, Thermo Fisher Scientific AG, 1/2000), a polyclonal rabbit anti-DSTN antibody
(PA1-24937, Thermo Fisher Scientific AG, 1/200), a monoclonal mouse anti-GAPDH anti-
body (MAB374, clone 6C5, Sigma-Aldrich Chemie GmbH, 1/200) and/or FITC-labeled phal-
loidin (P5282, Sigma-Aldrich Chemie GmbH, 25 μg/ml) in antibody diluent (Dako, Agilent
Technologies AG) overnight at 4˚C. For RHE and human skin biopsies, tissue sections were
deparaffinized and antigens retrieved by microwave heating in 10 mM citrate buffer, pH 6.
Slides were permeabilized, washed and incubated with a monoclonal mouse anti-hIL-38 anti-
body (H127C, Thermo Fisher Scientific AG, 1/2000) and/or a polyclonal rabbit anti-DSTN
antibody (PA1-24937, Thermo Fisher Scientific AG, 1/200) in antibody diluent overnight at
4˚C. Subsequently, primary antibodies were detected with rhodamine-labeled donkey anti-
goat IgG (705-025-003, Jackson Immuno Research Europe Ltd, Ely, UK, 1/200), Alexa Fluor
594-labeled goat anti-mouse IgG2b (115-585-207, Jackson Immuno Research Europe Ltd, 1/
200), Alexa Fluor 555-labeled goat anti-mouse IgG (A21422, Thermo Fisher Scientific AG, 1/
800), Alexa Fluor 594-labeled donkey anti-rabbit IgG (A21422, Thermo Fisher Scientific AG,
1/1000), and/or Alexa Fluor 488-labeled donkey anti-rabbit IgG (711-545-152, Jackson
Immuno Research Europe Ltd, 1/200) secondary antibodies, as appropriate, and slides were
stained with 4’,6-diamidino-2-phenylindole (DAPI; D3571,Thermo Fisher Scientific AG, 1/
2000 in PBS) and mounted in FluoreGuard medium (ScyTek Laboratories, Inc., Logan, UT).
To assess staining specificity, negative controls were performed with isotype-matched control
antibodies or in absence of primary antibodies. In addition, the specificity of IL-38 detection
was assessed in monolayer cultures by using control cells lacking IL-38 expression and in RHE
by preadsorbing the anti-IL-38 antibody with a 20-fold molar excess of recombinant human
IL-38 (AG-40A-0191, Adipogen AG) before use. Slides were imaged with a LSM700 confocal
microscope (Carl Zeiss Microscopy, Feldbach, Switzerland) and the ZEN black software (Carl
Zeiss Microscopy). Co-localization was analyzed on single confocal sections using the Coloc
module of Imaris 9.3.1 (Bitplane AG, Zurich, Switzerland) with global manual thresholds set
according to the fluorescence signal intensities of isotype-matched control antibody-stained
samples. Results were represented using the co-localization channel tool of the software. Thre-
sholded Manders’ split co-localization coefficients were computed in 1–5 random microscopic
fields for each sample.
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Yeast 2 hybrid
An ULTImate yeast 2 hybrid (Y2H) screen was performed by Hybrigenics Services (Paris,
France), using amino acids (aa) 30–152 of human IL-38, C-terminally fused to the LexA DNA-
binding domain (DBD), as a bait. Indeed, IL-38 was suggested to undergo N-terminal process-
ing by as yet unidentified protease(s) [8], which might in principle be conserved in yeast. We
thus used an N-terminally truncated form of IL-38, starting downstream of the proposed
cleavage sites, to avoid potential proteolytic processing between the DBD and the IL-38 por-
tion of the bait. The N-LexA(DBD)-IL-38(aa30-152)-C fusion construct was cloned into the
pB27 vector and used to screen a human reconstituted skin (EpiSkin, Lyon, France)_RP2 prey
library (complexity�107 primary clones) at a 10-fold coverage. A high stringency 3-amino-
1,2,4-triazole (3-AT) concentration (100.0 mM) was used to overcome auto-activation of the
bait fusion.
Immunoprecipitation and Western blotting
HEK 293T were seeded in 10-cm petri dishes and transiently transfected with pcDNA3.1/hIL-
38 and pcDNA3.1/hDSTN. Forty-eight hours after transfection, cellular proteins were cross-
linked with dithiobis(succinimidylpropionate) (DSP, Thermo Fisher Scientific AG), extracted
in lysis buffer (20 mM Tris/HCl, pH 8, 137 mM NaCl, 1% Nonidet P-40, 2 mM EDTA) supple-
mented with a protease inhibitor cocktail for 30 min on ice and cleared by centrifugation.
4x106 cell equivalents were immunoprecipitated with a polyclonal rabbit anti-DSTN antibody
(PA1-24937, Thermo Fisher Scientific AG, 4 μg) or with normal rabbit IgG (10500C, Thermo
Fisher Scientific AG, 4 μg) as a negative control. Alternatively, immunoprecipitation (IP) was
performed with a polyclonal goat anti-IL38 antibody (AF2427, R&D Systems, 4 μg) or with
normal goat IgG (005-000-003, Jackson Immuno Research Europe Ltd 4 μg) as a negative con-
trol. NHK/38 cells were seeded in 6-well plates at a density of 8x105 cells/well and incubated
on the following day with or without 1 μg/ml Dox for 24h. Cells were then lyzed by freeze-
thawing in TN buffer supplemented with protease inhibitors. Immunoprecipitated proteins
and total cell lysates (3x104 cell equivalents for HEK 293T cells, 8x104 cell equivalents for
NHK/38 cells) were separated electrophoretically on a 4–12% gradient SDS-PAGE (NuPAGE;
Thermo Fisher Scientific AG) and blotted onto PVDF membranes. The membranes were
blocked with 5% horse serum in TBS, 0.05% Triton X-100 (TBST) and probed with a biotiny-
lated polyclonal goat anti-IL38 antibody (BAF2427, R&D Systems, 1/1000) or with a polyclonal
rabbit anti-DSTN antibody (PA1-24937, Thermo Fisher Scientific AG, 1/5000) in TBST.
Immunoreactive bands were detected using streptavidin HRP (BD Biosciences, San Jose, CA,
1/3000) or an HRP-labeled anti-rabbit IgG secondary antibody (Bio-Rad Laboratories AG, 1/
10’000) and Radiance Plus chemiluminescent detection (Azure Biosystems, Dublin, CA) on a
LAS4000 imager (Fujifilm Life Science, Du¨sseldorf, Germany). After stripping in Re-Blot Plus
Strong antibody stripping solution (Merck & Cie) for 20 min at RT and blocking with TBST,
5% horse serum, the membranes were reprobed with the anti-DSTN antibody, the anti-IL38
antibody or a monoclonal mouse anti-GAPDH antibody (MAB374, clone 6C5, Sigma-Aldrich
Chemie GmbH, 1/2000) and appropriate HRP-labeled secondary reagents for ECL detection.
Proximity ligation assay
NHK/38 cells were seeded in chamber slides at a density of 1.6x105 cells/ and incubated on the
following day with or without 1 μg/ml Dox for 24h. Cells were fixed (PBS, 2% paraformalde-
hyde, then methanol), permeabilized (PBS, 0.1% Triton X-100) and washed (Dako wash buffer,
Agilent Technologies AG), before co-incubation with a polyclonal goat anti-IL38 antibody
(AF2427, R&D Systems, 1/1000) and a polyclonal rabbit anti-DSTN antibody (PA1-24937,
IL-38 localisation and interaction partners in keratinocytes
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Thermo Fisher Scientific AG, 1/200) in antibody diluent (Dako, Agilent Technologies AG).
Proximity ligation assay (PLA) probes (DuoLink, Sigma-Aldrich Chemie GmbH, Buchs, Swit-
zerland), diluted in antibody diluent, were then added to the slides, ligated, amplified and
washed, according to the manufacturer’s instructions. Slides were mounted using the DuoLink
in situ DAPI containing mounting medium. Negative controls were performed by incubation
of 24h Dox-treated and untreated NHK/38 cells with only one of the primary antibodies or
with antibody diluent alone. Slides were imaged with a LSM700 confocal microscope (Carl
Zeiss Microscopy) and the ZEN black software (Carl Zeiss Microscopy). PLA results were
quantified by manually counting the number of positive cells containing at least one PLA sig-
nal, normalized to the total number of cells per field, and the mean number of PLA spots per
positive cell in 2–4 random microscopic fields for each sample.
Statistical analysis
Data were analyzed with Prism version 8 (Graphpad Software, La Jolla, USA) using a one-way
ANOVA followed by Tukey’s multiple comparisons test or an unpaired Student’s t test, as
indicated. Values are expressed as mean ± SEM. Statistical significance was defined at a p-
value < 0.05.
Results
IL-38 (IL1F10) mRNA was constitutively expressed in normal human epidermis (IL-38/GUSB:
0.957 ± 0.563) (Fig 1A). In contrast, IL-38 levels in the dermis were low (IL-38/GUSB:
0.009 ± 0.008), in agreement with previous studies suggesting that keratinocytes are the main
source of IL-38 in the skin [4, 30, 33]. The mean IL-38 expression level was reduced more than
15 fold when primary human keratinocytes were isolated from epidermal sheets and grown in
2D culture, and only partially restored when the cells were cultured in presence of a high Ca++
concentration (2mM) to favor differentiation (Fig 1A). We thus set up a doxycycline (Dox)-
inducible IL-38 overexpression system using an immortalized normal human keratinocyte
(NHK) cell line [32] to investigate the localization and release of this cytokine in monolayer
cultures. Parental NHK cells expressed very low amounts of endogenous IL-38 mRNA (Fig
1A) and IL-38 protein levels were below the detection limit of a commercially available ELISA
(S1A Fig). IL-38 overexpressing NHK (NHK/38) cells already produced IL-38 mRNA (Fig 1A)
and low levels of IL-38 protein (S1 Fig) in the absence of Dox, reflecting leaky expression from
the inducible system at baseline. Treatment with Dox for 24h further enhanced IL-38 mRNA
(Fig 1A) and protein (S1A–S1C Fig) expression in NHK/38 cells.
In parallel, we used primary human keratinocytes in a 3D air-lift culture model to generate
in vitro reconstructed human epidermis (RHE). This 3D culture system allowed for efficient
induction of keratinocyte differentiation, as indicated by enhanced mRNA expression of dif-
ferentiation markers, such as keratin 10 (KRT10), involucrin (INV) and filaggrin (FLG), as
compared to cells in 2D culture, in low or high Ca++-containing media (S2A Fig). After 10
days of culture at the air-liquid interface, the cells formed a morphologically well-defined epi-
dermis-like structure including a basal, spinous, granular and cornified layer (S2B Fig). Immu-
nohistochemistry confirmed the presence of proliferating Ki-67 positive cells in the basal layer
and sequential expression of the differentiation markers KRT10, IVL and FIL in the upper lay-
ers of the epithelium (S2B Fig). Consistent with previously published data [30], the culture of
primary keratinocytes in RHE restored endogenous IL-38 mRNA and protein expression (Fig
1).
We then used Dox-treated NHK/38 cells to investigate extracellular release of IL-38 from
monolayer cultures. In parallel, we examined release of endogenous IL-38 from primary
IL-38 localisation and interaction partners in keratinocytes
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Fig 1. IL-38 expression and localization in human keratinocytes. A. IL-38 (IL1F10) mRNA expression, quantified by RTqPCR, is shown for normal human
epidermis, primary human keratinocytes cultured in monolayers (2D) in the presence of low (lo; 0.06 mM) or high (hi; 2 mM) Ca++, parental NHK cells, NHK/
38 cells without or with 24h Dox treatment, and RHE. IL-38 (IL1F10) mRNA levels are expressed relative to GUSB. Results are shown as individual values and
mean ± SEM for n = 5–6 different donors (epidermis and primary cells) or independent cultures (NHK cells). ����p<0.0001 vs. epidermis, primary 2D or RHE
cultures, NHK and NHK/38 –Dox cells, as assessed by one-way ANOVA, followed by Tukey’s multiple comparisons test. B. IL-38 protein levels, assessed by
ELISA, are shown in cell lysates and culture supernatants (SN) of Dox-treated NHK/38 cells kept in proliferation medium (loCa++) or switched to 1.8 mM Ca++
IL-38 localisation and interaction partners in keratinocytes
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human keratinocytes in RHE. In both instances, IL-38 was mainly (>95%) cell-associated, and
only a minor fraction of the protein was recovered in culture media (Fig 1B). We also exam-
ined the intracellular localization of the protein by immunofluorescence (IF). Confocal analy-
sis indicated that cell-associated IL-38 was preferentially, although not exclusively, cytoplasmic
in NHK/38 cells and in RHE (Fig 1C). In agreement with published data [9], IL-38 staining
was also detected in the epidermis of normal human skin, where the cytokine was predomi-
nantly cytoplasmic and essentially excluded from keratinocyte nuclei (Fig 1C). The specificity
of the anti-IL-38 staining in monolayer cultures, was validated by using NHK/38 cells without
Dox-treatment, as well as cells lacking IL-38 expression as negative controls (S1C and S3 Figs).
The AF2427 polyclonal and the H127C monoclonal anti-IL-38 antibodies used in this study
performed similarly and produced comparable staining patterns in cell monolayers (S3 Fig).
For detection of IL-38 in RHE and normal human skin, we favored the use of the H127C
monoclonal antibody, which has a better signal-to-noise ratio on paraffin sections, and the
specificity of IL-38 detection was assessed by using isotype controls and pre-adsorption of the
anti-IL-38 antibody with an excess of recombinant IL-38 protein (S4 Fig).
As information concerning the biology, regulation and mechanism(s) of action of IL-38 is
still scarce, we initiated a Y2H screen to identify IL-38-interacting proteins in the epidermis.
Human IL-38 (aa 30–152) was used as a bait to probe a reconstructed human epidermis
library, revealing high confidence interactions between IL-38 and six potential binding part-
ners (Table 2).
The highest number of interacting clones was obtained for destrin/actin-depolymerizing
factor (DSTN). Indeed, 42 prey fragments sharing a sequence corresponding to aa 43–148 of
DSTN were isolated in this experiment. Interaction between IL-38 and DSTN was confirmed
by co-immunoprecipitation of both interaction partners overexpressed in HEK 293T cells (Fig
2).
Molecular proximity between IL-38 and endogenous DSTN was further confirmed in
NHK/38 cells using a proximity ligation assay (PLA) (Fig 3; see S5 Fig for additional controls).
containing (hiCa++) differentiation medium for 3 days (left panel), as well as in RHE and in their 24h-conditioned media (right panel). Results are expressed as
ng IL-38 per mg of protein in the cell layer(s). Data are shown as individual values and mean ± SEM for n = 3 cultures (NHK/38 cells) or 3 different donors
(RHE) respectively. �p<0.05, ��p<0.001 vs. lysate, as assessed by paired Student’s t test. C. IL-38 protein expression in 24h Dox-treated NHK/38 cells (upper
panels), RHE (middle panels) and normal human skin (lower panels) was assessed by IF (red staining; all panels). Nuclei were labeled with DAPI (blue staining;
left panels). Results are representative of 5 independent experiments (NHK/38 cells) or 3 different donors (RHE and skin). Dotted lines outline the epidermal-
dermal border. Original magnification 63x.
https://doi.org/10.1371/journal.pone.0225782.g001
Table 2. Y2H preys.
Gene Name GenBank ID (NCBI)
Destrin—DSTN http://www.ncbi.nlm.nih.gov/nuccore/ 58530847
DNA-binding protein inhibitor—ID1 http://www.ncbi.nlm.nih.gov/nuccore/ 341865544
peroxiredoxin 1—PRDX1 http://www.ncbi.nlm.nih.gov/nuccore/ 320461710
peroxiredoxin 2—PRDX2 http://www.ncbi.nlm.nih.gov/nuccore/ 460417277
ring finger protein 39—RNF39 http://www.ncbi.nlm.nih.gov/nuccore/ 297206762
thrombospondin 2—THBS2 http://www.ncbi.nlm.nih.gov/nuccore/ 538918410
List of preys identified in an ULTImate Y2H SCREEN by using a human IL-38 (aa 30–152) bait fragment to screen
the human reconstituted skin_RP2 prey library. Vector: pB27 N-LexA-bait-C fusion. Processed clones: 255. Analyzed
interactions: 144 millions. 3AT concentration: 100.0 mM. Results were ranked into 4 categories from A (highest
confidence rank) to D. Only A-ranked preys are listed.
https://doi.org/10.1371/journal.pone.0225782.t002
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Multiple PLA signals, indicating spatial co-occurrence of IL-38 and DSTN, were observed in
99% of the Dox-treated NHK/38 cells.
The specificity of DSTN detection by IF was validated in cultured cells by DSTN overex-
pression and on paraffin sections by using isotype-matched control antibodies and staining
with secondary antibodies only (S6 Fig). By confocal microscopy, we then confirmed partial
co-localization of IL-38 and DSTN in NHK/38 cells in 2D culture, which was most striking in
peripheral cytoplasmic regions (Fig 4A). We similarly examined co-localization of DSTN and
F-actin, a known DSTN-interaction partner, which we used as a positive control, and of
GAPDH and DSTN, as an example of two proteins not necessarily expected to co-localize (S7
Fig). IL-38 co-localized significantly more with DSTN than GAPDH, as indicated by the
respective Manders’ co-localization coefficients for these proteins, while IL-38/DSTN and
DSTN/F-actin co-localization was comparable (Fig 4A). Endogenous IL-38 and DSTN were
Fig 2. Interaction of IL-38 and DSTN in HEK293T cells. Association of IL-38 and DSTN was examined by co-IP in HEK293T cells co-transfected with
pcDNA3.1/hIL-38 and pcDNA3.1/hDSTN. A. Cells were treated with DSP, lyzed and immunoprecipitated with a polyclonal rabbit anti-DSTN antibody
(right lane), or with normal rabbit IgG (left lane) as a negative control. Whole-cell lysates (input; middle lane) and immunoprecipitated proteins were
fractionated by SDS-PAGE and IL-38 was detected by Western blotting (upper panel). The membrane was then stripped and reprobed with the anti-DSTN
antibody (lower panel). B. Cells were treated with DSP, lyzed and immunoprecipitated with a polyclonal goat anti-IL-38 antibody (right lane), or with normal
goat IgG (left lane) as a negative control. Whole-cell lysates (input; middle lane) and immunoprecipitated proteins were fractionated by SDS-PAGE and
DSTN was detected by Western blotting (upper panel). The membrane was then stripped and reprobed with the anti-IL-38 antibody (lower panel). The
positions of IL-38 and DSTN, as well as of the heavy (HC) and light (LC) chains of the IgGs used for IP are indicated on the right of the blots. �indicates a
non-specific band present also in the negative control IP. Molecular mass markers are indicated on the left of each blot.
https://doi.org/10.1371/journal.pone.0225782.g002
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also co-expressed throughout the epidermis in RHE and in normal human skin (Fig 4B).
Finally, in NHK/38 2D cultures, IL-38 partially co-localized with F-actin (thresholded Man-
ders’ coefficient: IL-38/F-actin 0.803 ± 0.053, vs. DSTN/F-actin 0.727 ± 0.007, ns; for n = 3
independent microscopic fields in one experiment), in particular on the inner face of the corti-
cal actin network and in filopodia (Fig 5).
Fig 3. Interaction of IL-38 and DSTN in NHK/38 cells. A. A proximity ligation assay (PLA) was used to probe co-
localization of IL-38 and DSTN in NHK/38 cells without (upper panels) or with (lower panels) 24h Dox treatment.
After addition of PLA probes and signal amplification, PLA signals, indicating close proximity of the two target
proteins, were visualized as discrete red spots (all panels). Nuclei were labeled with DAPI (blue staining, right panels).
Original magnification 63x. B. PLA results were quantified in NHK/38 cells without (-) or with (+) 24h Dox treatment
by assessing the percentage of positive cells containing at least one PLA signal and the mean number of PLA spots per
positive cell. Negative controls were performed by incubating untreated and Dox-treated NHK/38 cells with the anti-
DSTN (αDSTN) antibody alone, the anti-IL-38 antibody (αIL-38) alone or antibody diluent only and quantified in
parallel. Results are shown as individual values and mean ± SEM. ��p<0.01, ���p<0.001, ����p<0.0001 vs. negative
controls incubated in absence of one or both antibodies, as assessed by one-way ANOVA, followed by Tukey’s multiple
comparisons test.
https://doi.org/10.1371/journal.pone.0225782.g003
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Fig 4. Co-localization of IL-38 and DSTN in human keratinocytes. A. Localization of IL-38 (red staining; upper left and right panels) and
DSTN (green staining; upper middle and right panels) was examined by confocal IF microscopy in 24h Dox-treated NHK/38 cells. Overlap
between the red and green fluorescence signals is visible in yellow in the merged image (upper right panel) and co-localization between IL-38
and DSTN, as assessed using the Imaris Coloc module, is illustrated in white in the co-localization channel (lower left panel). Thresholded
Manders’ coefficients for co-localization of IL-38 with DSTN, GAPDH with DSTN and DSTN with F-actin are shown as individual values and
mean ± SEM for n = 3–9 independent microscopic fields. ��p<0.01 IL-38/DSTN vs. GAPDH/DSTN. B. Localization of IL-38 (red staining;
left and right panels) and DSTN (green staining; middle and right panels) is shown for RHE (upper row) and normal human skin (lower row).
Partial spatial co-occurrence of IL-38 and DSTN is visible in yellow in the merged images (right panels). Results are representative of 3
cultures (NHK/38 cells), or 3 (RHE) or 2 (skin) different donors respectively. Dotted lines outline the epidermal-dermal border. Original
magnification 63x.
https://doi.org/10.1371/journal.pone.0225782.g004
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Discussion
In the present study, we investigated the subcellular localization of the IL-38 protein in human
keratinocytes using IL-38 overexpressing NHK/38 cells and RHE. Consistent with its lack of a
signal peptide for conventional secretion, IL-38 was mainly cell-associated in cultured kerati-
nocytes, both in monolayers and in RHE. It thus appears that neither proliferating nor differ-
entiated keratinocytes spontaneously release major amounts of IL-38. Most IL-1 family
cytokines lack signal sequences to direct them towards the classical secretory pathway and
many are released into the extracellular space upon cell stress or cell death [34]. Pyroptosis and
necroptosis, for instance, are frequently associated with the release of IL-1β and IL-18 [35].
Other IL-1 family members, such as IL-1α and IL-33, are typically released during various
forms of lytic cell death, thereby acting as alarmins to signal cell damage to the immune system
[36]. Finally, a previous study also reported IL-38 release during apoptosis [8]. It is thus con-
ceivable that, in particular situations, cell stress, activation and/or death, might cause IL-38 to
be either passively released, or even actively secreted. Indeed the related IL-1 family antagonist
Fig 5. Co-localization of IL-38 and F-actin in NHK/38 cells. Localization of IL-38 (red staining; first and third panels in each row) and
F-actin (green staining; second and third panels in each row) was examined by confocal IF microscopy in 24h Dox-treated NHK/38 cells.
Spatial co-occurrence of IL-38 and F-actin is visible in yellow in the merged images (third panel in each row) and co-localization between
IL-38 and F-actin, as assessed using the Imaris Coloc module, is illustrated in white (co-localization channel; last panel in each row). A.
Co-localization of IL-38 and F-actin was observed in particular on the inner face of the cortical F-actin network (arrows). B. Co-
localization of IL-38 and F-actin was also observed in filopodia (arrows, upper panels). A smaller ROI is magnified and shown in the lower
panels. Results are representative of 2 experiments. Original magnification 63x.
https://doi.org/10.1371/journal.pone.0225782.g005
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IL-1Ra, which is also constitutively produced as an intracellular protein in keratinocytes, was
shown to be released in response to mechanical stress or cytokine treatment [37–39]. In addi-
tion, the activity of many IL-1 family cytokines is enhanced by N-terminal processing [40].
This led to the suggestion that mature bioactive IL-38 might correspond to an N-terminally
truncated form of the protein [8]. However, specific cleavage site(s) and protease(s) involved
still remain to be characterized [8, 41–43].
Cell-associated IL-38 was predominantly cytoplasmic in cultured keratinocytes and in nor-
mal human epidermis. A Y2H screen revealed several potential IL-38-interacting molecules.
Interestingly, except for thrombospondin 2, all recovered clones encoded intracellular pro-
teins. High confidence interaction was observed in particular with the cytoplasmic protein
DSTN. This interaction was confirmed by co-immunoprecipitation of IL-38 and DSTN co-
expressed in HEK 293T cells. Molecular proximity of IL-38 with endogenous DSTN was fur-
ther validated by PLA in NHK/38 keratinocytes, where partial co-localization of IL-38 and
DSTN was also observed by IF. DSTN, together with the related protein cofilin-1, was previ-
ously shown to be essential for normal keratinocyte differentiation and skin homeostasis,
through its inhibitory effects on actin polymerization and stress fiber formation [44]. Consis-
tently, DSTN expression was detected in keratinocytes of all epidermal layers in RHE and in
normal human skin, where it partially co-localized with IL-38, suggesting that the two binding
partners may also interact in vivo. The functional consequences of this interaction are cur-
rently unclear. Intracellular binding partners could be involved in the regulation of IL-38 pro-
tein levels or function by affecting its localization, stability, maturation, and/or release.
Alternatively, as suggested for other IL-1 family members [45–48], intracellular IL-38 binding
proteins might represent bona fide interaction partners for intracellular functions of the cyto-
kine. Conversely, interaction with IL-38 might modulate DSTN function and thereby actin fil-
ament dynamics and cell homeostasis. Interestingly in this context, loss of DSTN function was
previously shown to induce an inflammatory phenotype in the corneal epithelium [49].
Finally, IL-38 partially co-localized with F-actin in NHK/38 cells, in particular on the inner
face of the cortical actin network. Furthermore, as previously described [50], isolated keratino-
cytes in culture extended numerous filopodia, lamellipodia and ruffles and IL-38 also co-local-
ized with actin filaments in filopodia. It is tempting to speculate that the proximity of IL-38
with the edge of the cells could facilitate the release of this cytokine in stress situations or upon
cell activation. In fact, despite the undisputed importance of the IL-1 and IL-36 systems in skin
inflammatory responses, the mechanisms regulating the unconventional leaderless secretion
and/or the passive release of the two constitutively expressed antagonists IL-1Ra and IL-36Ra
by keratinocytes are still unclear. It will thus be informative to explore whether intracellular
localization and/or interaction partners are shared between IL-38 and other IL-1 family
members.
In conclusion, at steady state, IL-38 is predominantly found in the cytoplasm of human ker-
atinocytes, where it interacts with DSTN. We observed partial co-localization of these two pro-
teins, as well as of IL-38 and F-actin. The functional relevance of this interaction remains to be
investigated.
Supporting information
S1 Fig. IL-38 expression in NHK/38 cells. A. IL-38 protein levels in NHK/38 cell lysates after
24h incubation without or with Dox were assessed by ELISA. Results are expressed as ng IL-38
per mg of cellular protein. Data are shown as individual values and mean ± SEM for triplicate
wells in one experiment representative of 4 independent cultures. �p<0.05 vs. NHK and
NHK/38 -Dox cells, as assessed by one-way ANOVA, followed by Tukey’s multiple
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comparisons test. B. IL-38 protein expression in NHK/38 cells without or with 24h Dox treat-
ment was assessed by Western blotting (upper panel). The membrane was then stripped and
reprobed with an anti-GAPDH antibody as a loading control (lower panel). Results are repre-
sentative of 2 experiments. C. IL-38 protein expression in NHK/38 cells without (left panels)
or with (right panels) 24h Dox treatment was assessed by IF (red staining; all panels). Nuclei
were labeled with DAPI (blue staining; upper panels). Results are representative of 5 indepen-
dent experiments. Original magnification 63x.
(PPTX)
S2 Fig. Epidermal differentiation of primary human keratinocytes in RHE. A. KRT10 (left
panel), IVL (middle panel) and FLG (right panel) mRNA levels were assessed by RT-qPCR in
primary human keratinocytes cultured in monolayers (2D) in presence of low (lo; 0.06mM) or
high (hi; 2mM) Ca++, or in RHE. Transcript levels are expressed relative to GUSB. Results are
shown as individual values and mean ± SEM for 6 (2D cultures) or 4 (RHE) different donors.
�p<0.05, ����p>0.0001 vs. 2D cultures, as assessed by one-way ANOVA, followed by Tukey’s
multiple comparisons test. B. The structure of the RHE was examined by HE staining (upper
left panel). After 10 days of culture at the air-liquid interface, the cells formed a morphologi-
cally well-defined epidermis-like structure with (from bottom to top) basal (B), spinous (S),
granular (G) and cornified (C) layers similar to in vivo skin. Protein expression of keratinocyte
proliferation (Ki67; brown staining, upper right panel) and differentiation (KRT10, IVL, FLG;
brown staining, lower panels) markers was assessed by IHC. Original magnification 10x.
(PPTX)
S3 Fig. Specificity of IL-38 detection by IF in cell monolayers. IL-38 was detected by IF in
HEK 293T cells transfected with pcDNA3.1/hIL-38 (red staining, overexpressed IL-38; upper
panels) or with empty pcDNA3.1 as a negative control (lower panels) using the AF2427 poly-
clonal goat anti-IL-38 antibody (A) or the H127C monoclonal mouse anti-IL-38 antibody (B).
IL-38 was detected by IF in 24h Dox-treated NHK/38 cells (red staining, overexpressed IL-38;
upper panels) or NHK/lacZ cells used as a negative control (lower panels) using the AF2427
polyclonal goat anti-IL-38 antibody (C) or the H127C monoclonal mouse anti-IL-38 antibody
(D). Nuclei were labeled with DAPI (blue staining; left panels). Original magnification 40x.
(PPTX)
S4 Fig. Specificity of IL-38 detection by IF in RHE and skin. A. IL-38 was detected by IF in
RHE using a monoclonal mouse anti-IL-38 antibody (red staining; upper panels) or normal
mouse IgG as a negative control (lower panels). Nuclei were labeled with DAPI (blue staining;
left panels). Results are representative of 5 independent experiments. Original magnification
63x. B. IL-38 protein expression in RHE was examined by IF using a monoclonal mouse anti-
IL-38 antibody (red staining; upper panels) or the same antibody pre-adsorbed with recombi-
nant human IL-38 (lower panels). Nuclei were labeled with DAPI (blue staining; left panels).
Results are representative of 2 independent experiments. Original magnification 63x. C. IL-38
protein expression in normal human skin was assessed by IF using a monoclonal mouse anti-
IL-38 antibody (red staining; upper panels) or normal mouse IgG as a negative control (lower
panels). Nuclei were labeled with DAPI (blue staining; left panels). Results are representative
of 3 different donors. Dotted lines outline the epidermal-dermal border. Original magnifica-
tion 40x.
(PPTX)
S5 Fig. Specificity of the detection of IL-38-DSTN interactions by PLA. Negative controls
for the PLA experiment were performed by incubation of 24h Dox-treated NHK/38 cells with
the anti-DSTN antibody alone (upper panels), the anti-IL-38 antibody alone (middle panels)
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or antibody diluent only (lower panels). After addition of PLA probes and signal amplification,
only minimal background staining was observed (red staining; all panels). Nuclei were labeled
with DAPI (blue staining, right panels). Original magnification 63x.
(PPTX)
S6 Fig. Specificity of DSTN detection by IF in cell monolayers, RHE and skin. A. DSTN
was detected by IF in HEK 293T cells transfected with pcDNA3.1/hDSTN (green staining,
overexpressed DSTN; upper panels) or empty pcDNA3.1 (green staining, endogenous DSTN;
middle panels) using a polyclonal rabbit anti-DSTN antibody. Staining with normal rabbit
IgG, used as a negative control, is shown for HEK293T cells transfected with pcDNA3.1/
hDSTN (lower panels). Nuclei were labeled with DAPI (blue staining; left panels). Original
magnification 20x. B. DSTN was detected by IF in RHE using a polyclonal rabbit anti-DSTN
antibody (green staining; upper panels). Detection with the labeled secondary anti-rabbit anti-
body alone is shown as a negative control (lower panels). Nuclei were labeled with DAPI (blue
staining; left panels). Results are representative of 3 experiments. Original magnification 63x.
C. DSTN protein expression in normal human skin was assessed by IF using a polyclonal rab-
bit anti-DSTN antibody (green staining; upper panels) or normal rabbit IgG as a negative con-
trol (lower panels). Nuclei were labeled with DAPI (blue staining; left panels). Results are
representative of 3 experiments. Dotted lines outline the epidermal-dermal border. Original
magnification 63x.
(PPTX)
S7 Fig. Localization of GAPDH, DSTN and F-actin in NHK/38 cells. A. Localization of
GAPDH (red staining; upper left and right panels) and DSTN (green staining; upper middle
and right panels) was examined by confocal IF microscopy in 24h Dox-treated NHK/38 cells.
Overlap between the red and green fluorescence signals is visible in yellow in the merged
image (upper right panel). Co-localization between GAPDH and DSTN is illustrated in white
in the co-localization channel (lower left panel). B. Localization of DSTN (red staining; upper
left and right panels) and F-actin (green staining; upper middle and right panels) was exam-
ined by confocal IF microscopy in 24h Dox-treated NHK/38 cells. Overlap between the red
and green fluorescence signals is visible in yellow in the merged image (upper right panel).
Co-localization between DSTN and F-actin is illustrated in white (co-localization channel;
lower left panel). Results are representative of 2 (GAPDH/DSTN) or 1 (DSTN/F-actin) experi-
ment(s). Original magnification 63x.
(PPTX)
S1 Images. Original uncropped and unadjusted images of Western blots. This file includes
the original uncropped and unadjusted images of the Western blots shown in Fig 2A, Fig 2B
and S1B Fig.
(PDF)
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